Wyoming senators reap largesse from biotechnology firm Amgen
News | 29 January 2013
A California biotechnology company set to benefit by millions of dollars from a last-minute addition to the January 1 ?Fiscal Cliff? bill is among the top campaign contributors to Wyoming U.S. Senators Mike Enzi and John Barrasso. Both senators were ...
Click on the link to read the full article at WyoFile
(This link will open in a new window)
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
